Medtech Money  cover image

Episode 118: Amar Sawhney, General Partner of Incept & CEO of Instylla and Rejoni | Brains, Sweat and Money: Self-Funding and Raising Capital for 25 Startups

Medtech Money

00:00

How I Survived the Pain of Losing My Platform Technology From My First Acquisition

FOCO was acquired by Genzyme, a company that has been around since the 1970s. FOCO started out as an engineering graduate student working on surgical sealants to be able to seal leaks from tissue. The technology they created is now used in growing organs and 3D printing. But it took them years to get FDA approval for their lung sealant.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app